Chemoinformaics analysis of N-PROPYL-AMINE
| Molecular Weight | 59.112 | nRot | 1 |
| Heavy Atom Molecular Weight | 50.04 | nRig | 0 |
| Exact Molecular Weight | 59.0735 | nRing | 0 |
| Solubility: LogS | 1.065 | nHRing | 0 |
| Solubility: LogP | 0.444 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 13 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 4 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 12.1111 |
| nHD | 1 | BPOL | 8.45886 |
| QED | 0.463 |
| Synth | 2.008 |
| Natural Product Likeliness | 0.353 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.016 |
| HIA | 0.006 |
| CACO-2 | -4.865 |
| MDCK | 0.000506912 |
| BBB | 0.855 |
| PPB | 0.0599306 |
| VDSS | 1.261 |
| FU | 0.900743 |
| CYP1A2-inh | 0.271 |
| CYP1A2-sub | 0.381 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.747 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.396 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.871 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.231 |
| CL | 8.122 |
| T12 | 0.661 |
| hERG | 0.038 |
| Ames | 0.026 |
| ROA | 0.957 |
| SkinSen | 0.471 |
| Carcinogencity | 0.162 |
| EI | 0.445 |
| Respiratory | 0.927 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.955861 |